Nano-miR-133a Replacement Therapy Blunts Pressure Overload–Induced Heart Failure-Reference-Cited by-同舟云学术

Nano-miR-133a Replacement Therapy Blunts Pressure Overload–Induced Heart Failure

Published:2021-12-14 Issue:24 Volume:144 Page:1973-1976
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Modica Jessica¹²,Di Mauro Vittoria¹³^ORCID,Barandalla-Sobrados Maria¹³^ORCID,Chavez Samuel Elias Pineda³⁴^ORCID,Carullo Pierluigi¹³^ORCID,Nemska Simona³^ORCID,Anselmo Achille³,Condorelli Gianluigi¹²,Iafisco Michele⁵,Miragoli Michele¹³⁴^ORCID,Catalucci Daniele¹³^ORCID

Affiliation:

1. National Research Council–Institute of Genetics and Biomedical Research, Milan Unit, Italy (J.M., V.D.M., M.B.-S., P.C., G.C., M.M., D.C.).

2. Humanitas University, Pieve Emanuele (Milan), Italy (G.C., J.M.).

3. IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy (V.D.M., M.B.-S., S.E.P.C., P.C., S.N., A.A., M.M., D.C.).

4. Department of Medicine and Surgery, University of Parma, Italy (S.E.P.C., M.M.).

5. National Research Council–Institute of Science & Technology for Ceramics, Faenza, Italy (M.I.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055866

Reference5 articles.

1. The growth of siRNA-based therapeutics: Updated clinical studies

2. Inhalation of peptide-loaded nanoparticles improves heart failure

3. Cardiac Disease Status Dictates Functional mRNA Targeting Profiles of Individual MicroRNAs

4. MicroRNA-133 Modulates the β 1 -Adrenergic Receptor Transduction Cascade

5. miR-133a mediates the hypoxia-induced apoptosis by inhibiting TAGLN2 expression in cardiac myocytes

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current concepts in the epigenetic regulation of cardiac fibrosis;Cardiovascular Pathology;2024-11

2. Epigenetic regulation of diverse regulated cell death modalities in cardiovascular disease: Insights into necroptosis, pyroptosis, ferroptosis, and cuproptosis;Redox Biology;2024-10

3. MicroRNAs and therapeutic potentials in acute and chronic cardiac disease;Drug Discovery Today;2024-09

4. Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice;Nature Communications;2024-07-18

5. Non-Coding Ribonucleic Acids as Diagnostic and Therapeutic Targets in Cardiac Fibrosis;Current Heart Failure Reports;2024-03-15